AngioDynamics Net Current Assets as percentage of Total Assets from 2010 to 2023
ANGO Stock  USD 9.64 0.18 1.90% 
AngioDynamics  Net Current Assets as percentage of Total Assets 
Check AngioDynamics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AngioDynamics main balance sheet or income statement drivers, such as Direct Expenses of 130.8 M, Cost of Revenue of 131.1 M or Gross Profit of 145.1 M, as well as many exotic indicators such as Interest Coverage of 2.76, Long Term Debt to Equity of 0.0695 or PPandE Turnover of 6.82. AngioDynamics financial statements analysis is a perfect complement when working with AngioDynamics Valuation or Volatility modules. It can also supplement AngioDynamics' financial leverage analysis and stock options assessment as well as various AngioDynamics Technical models . Check out the analysis of AngioDynamics Correlation against competitors. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
AngioDynamics Net Current Assets as percentage of Total Assets Breakdown
Showing smoothed Net Current Assets as percentage of Total Assets of AngioDynamics with missing and latest data points interpolated. AngioDynamics' Net Current Assets as percentage of Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AngioDynamics' overall financial position and show how it may be relating to other accounts over time.
Net Current Assets as percentage of Total Assets  10 Years Trend 

Net Current Assets as percentage of Total Assets 
Timeline 
AngioDynamics Net Current Assets as percentage of Total Assets Regression Statistics
Arithmetic Mean  16.04  
Geometric Mean  14.95  
Coefficient Of Variation  44.34  
Mean Deviation  4.85  
Median  14.38  
Standard Deviation  7.11  
Sample Variance  50.59  
Range  24.42  
RValue  (0.1)  
Mean Square Error  54.30  
RSquared  0.009189  
Significance  0.74  
Slope  (0.16)  
Total Sum of Squares  657.70 
AngioDynamics Net Current Assets as percentage of Total Assets History
2023  17.85  
2022  14.36  
2021  12.49  
2020  14.84  
2019  17.08  
2018  28.93  
2017  15.7  
2016  11.64  
2015  10.94  
2014  12.24  
2013  9.99 
About AngioDynamics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include AngioDynamics income statement, its balance sheet, and the statement of cash flows. AngioDynamics investors use historical funamental indicators, such as AngioDynamics's Net Current Assets as percentage of Total Assets, to determine how well the company is positioned to perform in the future. Although AngioDynamics investors may use each financial statement separately, they are all related. The changes in AngioDynamics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AngioDynamics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on AngioDynamics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in AngioDynamics. Please read more on our technical analysis and fundamental analysis pages.
Last Reported  Projected for 2023  
Net Current Assets as percentage of Total Assets  14.36  17.85  
Average Assets  496.3 M  553 M 
AngioDynamics Investors Sentiment
The influence of AngioDynamics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decisionmaking process regarding taking a position in AngioDynamics. The overall investor sentiment generally increases the direction of a stock movement in a oneyear investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to AngioDynamics' public news can be used to forecast risks associated with an investment in AngioDynamics. The trend in average sentiment can be used to explain how an investor holding AngioDynamics can time the market purely based on public headlines and social activities around AngioDynamics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
AngioDynamics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for AngioDynamics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average AngioDynamics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on AngioDynamics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AngioDynamics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AngioDynamics' short interest history, or implied volatility extrapolated from AngioDynamics options trading.
Pair Trading with AngioDynamics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.Moving together with AngioDynamics Stock
+  0.71  CI  Cigna Corp  Fiscal Quarter End 30th of June 2023  PairCorr 
Moving against AngioDynamics Stock
  0.86  ECOR  Electrocore LLC  Fiscal Quarter End 30th of June 2023  PairCorr  
  0.82  ABC  AmerisourceBergen  Fiscal Quarter End 30th of June 2023  PairCorr  
  0.81  ABT  Abbott Laboratories  Fiscal Quarter End 30th of June 2023  PairCorr  
  0.77  EW  Edwards Lifesciences Corp  Fiscal Quarter End 30th of June 2023  PairCorr  
  0.62  ENSG  Ensign Group  Fiscal Quarter End 30th of June 2023  PairCorr 
The ability to find closely correlated positions to AngioDynamics could be a great tool in your taxloss harvesting strategies, allowing investors a quick way to find a similarenough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics  that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between 1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better riskadjusted return on your portfolios.Check out the analysis of AngioDynamics Correlation against competitors. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sectorfocused investing themes.
Complementary Tools for AngioDynamics Stock analysis
When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data  
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals  
Transaction History View history of all your transactions and understand their impact on performance  
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and riskadjusted market performance  
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sectorfocused investing themes  
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the meanvariance optimization algorithm  
CEO Directory Screen CEOs from public companies around the world  
Transaction History View history of all your transactions and understand their impact on performance  
Focused Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences  
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities  
Performance Analysis Check effects of meanvariance optimization against your current asset allocation 
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96)  Revenue Per Share 8.501  Quarterly Revenue Growth 0.091  Return On Assets (0.0283)  Return On Equity (0.09) 
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.